The Secret Of Recombinant Human Acvr2b/activinr-iib Protein (fc Tag)(active) 80% Off - Today Only [NXCjy0Gp]

Recombinant Human ACVR2B Protein

The Recombinant Human ACVR2B Protein (Fc Tag)(Active) is a cutting-edge recombinant protein that plays a crucial role in the activin and myostatin signaling pathway. This high-quality protein, produced through a sophisticated HEK293 cell expression system, offers unparalleled purity and bio-activity, making it an invaluable tool for researchers studying skeletal muscle development, regeneration, and diseases associated with activin receptor type IIB.

• Expression Host: HEK293 Cells
• Calculated Molecular Weight: 40.0 kDa
• Bio-activity: Demonstrated by its ability to neutralize Activin-mediated inhibition on MPC11 cell proliferation and bind Human ACVR2B hFc with high affinity

Product Properties and Specifications

The Recombinant Human ACVR2B Protein (Fc Tag)(Active) is meticulously characterized for purity and activity. With a purity of >97% as determined by reducing SDS-PAGE and an endotoxin level of <1.0 EU per μg, this protein ensures reliable and consistent results in your experiments. Its storage and shipping conditions are optimized to maintain stability and ensure product longevity.

• Purity: >97% as determined by reducing SDS-PAGE
• Endotoxin: <1.0 EU per μg as determined by the LAL method
• Storage: Lyophilized, stable at -20 to -80℃ for up to 12 months

Applications and Benefits

The Recombinant Human ACVR2B Protein (Fc Tag)(Active) is an essential component for various research applications, including the study of skeletal muscle growth, regeneration, and activin-related diseases. By providing a reliable and potent source of ACVR2B, this protein allows researchers to explore the complex interplay of activin and myostatin signaling, paving the way for potential therapeutic interventions. Its high purity, bio-activity, and convenient handling make it a preferred choice for scientists seeking reliable results in their studies.

• Studying skeletal muscle growth and regeneration
• Investigating activin and myostatin signaling pathway
• Development of potential therapeutic interventions for activin-related diseases